209 related articles for article (PubMed ID: 8962143)
1. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
[TBL] [Abstract][Full Text] [Related]
2. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
[TBL] [Abstract][Full Text] [Related]
3. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
[TBL] [Abstract][Full Text] [Related]
4. TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle.
Dierov J; Xu Q; Dierova R; Carroll M
Blood; 2002 Mar; 99(5):1758-65. PubMed ID: 11861293
[TBL] [Abstract][Full Text] [Related]
5. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
6. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.
Golub TR; Barker GF; Lovett M; Gilliland DG
Cell; 1994 Apr; 77(2):307-16. PubMed ID: 8168137
[TBL] [Abstract][Full Text] [Related]
7. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.
Besançon F; Atfi A; Gespach C; Cayre YE; Bourgeade MF
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8081-6. PubMed ID: 9653143
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein.
Sjöblom T; Boureux A; Rönnstrand L; Heldin CH; Ghysdael J; Ostman A
Oncogene; 1999 Nov; 18(50):7055-62. PubMed ID: 10597306
[TBL] [Abstract][Full Text] [Related]
10. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
Jousset C; Carron C; Boureux A; Quang CT; Oury C; Dusanter-Fourt I; Charon M; Levin J; Bernard O; Ghysdael J
EMBO J; 1997 Jan; 16(1):69-82. PubMed ID: 9009269
[TBL] [Abstract][Full Text] [Related]
11. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.
Lacronique V; Boureux A; Valle VD; Poirel H; Quang CT; Mauchauffé M; Berthou C; Lessard M; Berger R; Ghysdael J; Bernard OA
Science; 1997 Nov; 278(5341):1309-12. PubMed ID: 9360930
[TBL] [Abstract][Full Text] [Related]
12. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
[TBL] [Abstract][Full Text] [Related]
13. ARG tyrosine kinase activity is inhibited by STI571.
Okuda K; Weisberg E; Gilliland DG; Griffin JD
Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
[TBL] [Abstract][Full Text] [Related]
14. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
Nguyen MH; Ho JM; Beattie BK; Barber DL
J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
[TBL] [Abstract][Full Text] [Related]
15. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
16. TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.
Tomasson MH; Williams IR; Hasserjian R; Udomsakdi C; McGrath SM; Schwaller J; Druker B; Gilliland DG
Blood; 1999 Mar; 93(5):1707-14. PubMed ID: 10029600
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
[TBL] [Abstract][Full Text] [Related]
18. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
19. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
20. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
Ross TS; Gilliland DG
J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
